\
&
Contact us
\
&
Contact us
This was 4 years ago
Locationwebinar
ProgrammesThis webinar is presented by EMDESK in cooperation with Mr. Massimiliano Esposito, Deputy Head of Unit Horizon Strategic Planning and Programming at Common Policy Centre of the European Commission’s Directorate-General for Research & Innovation.
Mr. Esposito will give a general introduction on the programme and its novelties covering topics such as: missions, strategic planning, the European Innovation Council, and planning for the first work programmes/calls for proposals. The webinar will be followed by 20 min Q&A.
This webinar is free of charge.
Registration form can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
